Vor Biopharma Inc. (VOR)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NGS) NASDAQ (NGS) Primary $
18. 03
-1.31
-6.7735%
$
1.08B Market Cap
- P/E Ratio
- Div Yield
733,100 Volume
-1.43 Eps
$ 19.34
Previous Close 
Want to track VOR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
What's Going On With Penny Stock Blood Cancer-Focused Vor Biopharma On Friday?
Thursday, Vor Biopharma Inc. VOR announced new clinical data from its ongoing Phase 1/2 VBP101 study of patients with relapsed/refractory acute myeloid leukemia (AML) receiving trem-cel followed by Mylotarg.
Benzinga | 2 years ago
2026 © Marketlog. All Rights Reserved.
